CollPlant Biotechnologies Ltd. (CLGN:NASDAQ) Investor Relations Material

Overview

CollPlant Biotechnologies Ltd., a pioneering company in the field of regenerative and aesthetic medicine, is focused on adopting three-dimensional (3D) bioprinting for tissue and organ generation, as well as medical aesthetics in key markets such as the United States, Canada and Europe. The firm has successfully developed a range of products based on recombinant type I human collagen, thanks to its exclusive plant-based genetic engineering technology. These innovative products include BioInks designed for 3D printing of tissues and organs; dermal filler and soft tissue fillers that can effectively treat wrinkles; 3D bioprinted breast implants intended to assist in breast tissue regeneration; injectable implants, formulated to aid in breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, which is suitable for the treatment of tendinopathy; as well as VergenixFG, an advanced wound care product with applications for patients in need of the treatment of deep surgical incisions and wounds, such as diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. CollPlant Biotechnologies Ltd. operates under the umbrella of several highly valued joint venture arrangements and strategic collaborations, including partnerships with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. Founded in 2004, the company was formerly known as CollPlant Holdings Ltd. and only recently rebranded as CollPlant Biotechnologies Ltd. in June 2019. Currently headquartered in Rehovot, Israel, CollPlant Biotechnologies Ltd. continues to be a key player in shaping the future of the regenerative medicine industry.

Frequently Asked Questions

What is CollPlant Biotechnologies Ltd.'s ticker?

CollPlant Biotechnologies Ltd.'s ticker is CLGN

What exchange is CollPlant Biotechnologies Ltd. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are CollPlant Biotechnologies Ltd.'s headquarters?

They are based in Rehovot, Israel

How many employees does CollPlant Biotechnologies Ltd. have?

There are 11-50 employees working at CollPlant Biotechnologies Ltd.

What is CollPlant Biotechnologies Ltd.'s website?

It is https://collplant.com/

What type of sector is CollPlant Biotechnologies Ltd.?

CollPlant Biotechnologies Ltd. is in the Healthcare sector

What type of industry is CollPlant Biotechnologies Ltd.?

CollPlant Biotechnologies Ltd. is in the Biotechnology industry

Who are CollPlant Biotechnologies Ltd.'s peers and competitors?

The following five companies are CollPlant Biotechnologies Ltd.'s industry peers:

- Millendo Therapeutics, Inc.

- 9 Meters Biopharma, Inc.

- MeiraGTx

- MacroGenics

- Bellicum Pharmaceuticals Inc